BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38424177)

  • 21. Prediction of Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma by CT Radiomics.
    Peng Y; Zhang ZT; Wang TT; Wang Y; Li CH; Zuo MJ; Lin HS; Gong LG
    Acad Radiol; 2023 Jul; 30(7):1400-1407. PubMed ID: 36220726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer.
    Iwano S; Ito S; Kamiya S; Ito R; Kato K; Naganawa S
    Nagoya J Med Sci; 2020 May; 82(2):205-215. PubMed ID: 32581401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine learning-based multiparametric MRI radiomics for predicting the aggressiveness of papillary thyroid carcinoma.
    Wang H; Song B; Ye N; Ren J; Sun X; Dai Z; Zhang Y; Chen BT
    Eur J Radiol; 2020 Jan; 122():108755. PubMed ID: 31783344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer.
    Tresoldi AS; Sburlati LF; Rodari M; Schinkelshoek MS; Perrino M; De Leo S; Montefusco L; Colombo P; Arosio M; Lania AGA; Fugazzola L; Chiti A
    J Endocrinol Invest; 2014 Aug; 37(8):709-714. PubMed ID: 24844565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
    Cailleux AF; Baudin E; Travagli JP; Ricard M; Schlumberger M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):175-8. PubMed ID: 10634383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiomics Analysis of Computed Tomography for Prediction of Thyroid Capsule Invasion in Papillary Thyroid Carcinoma: A Multi-Classifier and Two-Center Study.
    Wu X; Yu P; Jia C; Mao N; Che K; Li G; Zhang H; Mou Y; Song X
    Front Endocrinol (Lausanne); 2022; 13():849065. PubMed ID: 35692398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.
    Sohn SY; Choi JY; Jang HW; Kim HJ; Jin SM; Kim SW; Suh S; Hur KY; Kim JH; Chung JH; Kim SW
    Thyroid; 2013 Jun; 23(6):741-7. PubMed ID: 23205883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation analysis of I-131 SPECT/CT uptake parameters with the success ablation treatment of thyroid remnant in patients with low-intermediate-risk differentiated thyroid cancer.
    Zhang Q; Xu W
    Nucl Med Commun; 2022 Oct; 43(10):1051-1057. PubMed ID: 35972341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer.
    Ha S; Oh SW; Kim YK; Koo do H; Jung YH; Yi KH; Chung JK
    J Korean Med Sci; 2015 Jul; 30(7):876-81. PubMed ID: 26130949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
    Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
    Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of fractionated doses of iodine-131 for ablation of thyroid remnants.
    Wang SJ; Liu TJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jul; 65(7):336-40. PubMed ID: 12365652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound-based radiomics nomogram combined with clinical features for the prediction of central lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis.
    Jin P; Chen J; Dong Y; Zhang C; Chen Y; Zhang C; Qiu F; Zhang C; Huang P
    Front Endocrinol (Lausanne); 2022; 13():993564. PubMed ID: 36060946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A radiomics nomogram for the ultrasound-based evaluation of central cervical lymph node metastasis in papillary thyroid carcinoma.
    Wen Q; Wang Z; Traverso A; Liu Y; Xu R; Feng Y; Qian L
    Front Endocrinol (Lausanne); 2022; 13():1064434. PubMed ID: 36531493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Prates BS; Silva LC; Calsolari MR
    Thyroid; 2012 Nov; 22(11):1140-3. PubMed ID: 23050786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer.
    Zhou Y; Su GY; Hu H; Tao XW; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
    Acad Radiol; 2022 Mar; 29 Suppl 3():S222-S231. PubMed ID: 34366279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
    Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
    J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of ablation with low radioiodine activity in patients with papillary thyroid carcinoma and predictive value of postoperative nonstimulated thyroglobulin.
    Rosario PW; Mourão GF; Calsolari MR
    Nucl Med Commun; 2016 Oct; 37(10):1024-9. PubMed ID: 27306852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance imaging (MRI) radiomics of papillary thyroid cancer (PTC): a comparison of predictive performance of multiple classifiers modeling to identify cervical lymph node metastases before surgery.
    Qin H; Que Q; Lin P; Li X; Wang XR; He Y; Chen JQ; Yang H
    Radiol Med; 2021 Oct; 126(10):1312-1327. PubMed ID: 34236572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.